Clinical Pharmacology of Potent New Bisphosphonates for Postmenopausal Osteoporosis

By Chapurlat Roland D.  

Treatments in Endocrinology, Vol. 4, Iss. 2, 2005-01 ,pp. : 115-125

Adis International

Access to resources Recommend Favorite

Suppression of follicular rupture with meloxicam, a cyclooxygenase-2 inhibitor: potential for emergency contraception

By Jesam Cristin   Salvatierra Ana Mara   Schwartz Jill L.   Croxatto Horacio B.  

Human Reproduction, Vol. 25, Iss. 2, 2010-02 ,pp. : 368-373

Oxford University Press

Access to resources Recommend Favorite

Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib

By White W.B.   Faich G.   Borer J.S.   Makuch R.W.  

ACC Current Journal Review, Vol. 12, Iss. 6, 2003-11 ,pp. : 14-15

Elsevier

Access to resources Recommend Favorite

Withaferin A is a potent inhibitor of angiogenesis

By Mohan Royce   Hammers Hans   Bargagna-mohan Paola   Zhan Xiaoguo   Herbstritt Christopher   Ruiz Antonio   Zhang Li   Hanson Art   Conner Barry   Rougas John   Pribluda Victor  

Angiogenesis, Vol. 7, Iss. 2, 2004-01 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis

By Olivares C.   Bilotas M.   Buquet R.   Borghi M.   Sueldo C.   Tesone M.   Meresman G.  

Human Reproduction, Vol. 23, Iss. 12, 2008-12 ,pp. : 2701-2708

Oxford University Press

Access to resources Recommend Favorite